查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球溶酵素体贮积症治疗市场规模、份额和行业趋势分析报告：2022-2028 年各疾病类型、治疗类型、最终用户和地区的展望和预测
市场调查报告书
商品编码
1126409

全球溶酵素体贮积症治疗市场规模、份额和行业趋势分析报告：2022-2028 年各疾病类型、治疗类型、最终用户和地区的展望和预测

Global Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Type of Therapy By End User, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 230 Pages | 订单完成后即时交付

价格

到 2028 年，溶酵素体贮积病治疗的全球市场规模预计将达到 110 亿美元，在预测期内以 6.3% 的复合年增长率增长。

溶酵素体水解酵素的突变与细胞大分子的降解有关，是导致 LSD 的主要原因，占三分之二以上的病例。因此，LSD 的贮藏产物中存在多种生化来源，包括脂质、糖原、粘多醣和糖蛋白。除 X 连锁法布里病、达农病和亨特病外，所有 LSD 均为常染色体隐性遗传。

LSD，单独或作为多系统疾病的一部分，在临床上具有高度异质性，影响大多数器官。虽然溶酵素体酵素是看家基因，在大多数细胞中都有表达，但它们作用的组织分布并不均匀，这使得很难确定哪些组织受到影响。我已经决定了。

COVID-19 影响分析

COVID-19 公共卫生危机正在影响几乎所有行业。 COVID-19 的爆发影响了多个行业，尤其是卫生和製药行业，因为冠状病毒危机席捲全球，迫使医护人员将大部分资金用于抗击 COVID-19。这导致对 COVID-19 的需求显着减少整个领域溶酵素体贮积病药物的市场规模。感染风险是导致溶酵素体贮积症患者在医院延误治疗的主要因素。 COVID-19 的爆发将减缓全球溶酵素体贮积病治疗市场的发展，从而损害其 2022 年以后的市场价值。

市场增长因素

溶酵素体贮积病的患病率正在上升

酵素替代疗法市场的主要驱动力是扩大用于诊断和治疗溶酵素体贮积病的药物开发的研发。溶酵素体贮积病患病率的上升将是加速市场增长率的关键因素。美国国家生物技术信息中心发布的一份报告显示，2020 年 1 月白人男性社区法布里病的患病率为 1:17,000 至 1:117,000。非典型表现与女性约 1:6000 至 1:40,000 和男性约 1:1000 至 1:3000 相关，而男性 1:22,000 至 1:40,000 携带经典的法布里突变。

孤儿药开发的财政激励措施以收回研发成本

影响溶酵素体贮积症药物市场增长率的一个重要因素是医疗费用的增加（这有助于基础设施的发展）。各政府机构为加强医疗基础设施而增加资金的努力将进一步影响市场动态。此外，由于早期诊断接受率的提高和政府提高认识的计划增加，溶酵素体贮积病治疗市场预计将增长。与此相伴的是，政府慈善项目的扩大和可支配收入的增加将加速市场的扩张。

市场製约因素

干细胞疗法存在很多问题

移植后不久出现的许多问题是由于药物或辐射立即破坏了骨髓。在某些情况下，调节程序本身可能会产生意想不到的后果。患者可以从移植团队获得支持以管理副作用。大多数可以管理以使患者感觉更好，有些可以预防。这不是一个完整的列表，因此请告知您的医生或移植团队您遇到的任何问题或调整。

按疾病类型划分的前景

根据疾病类型，溶酵素体贮积病治疗市场分为戈谢病、法布里病、庞贝综合征、粘多醣贮积症等。 2021 年，戈谢病部门在溶酵素体贮积病治疗市场中获得了最高的收入份额。这是因为戈谢病患病率的上升是主要的市场驱动力。此外，该领域的增长将受到强大的批准药物和正在开发的新疗法的推动。

按治疗类型划分的前景

溶酵素体贮积病治疗市场按治疗类型分为酵素替代疗法、干细胞疗法、底物减少疗法等。干细胞治疗部门将在 2021 年在溶酵素体贮积病治疗市场中获得可观的收入份额。 LSD 通过分泌再摄取溶酵素体水解酵素进行交叉校正的能力使其成为干细胞治疗非常有吸引力的目标，而骨髓同种异体移植是第一个应用于 LSD 的特定治疗方式。

最终用户视角

溶酵素体贮积病治疗市场按最终用户细分为医院、诊所等。由于越来越多的人因溶酵素体贮积病寻求住院治疗，医院部门在 2021 年的溶酵素体贮积病治疗市场中获得了最高的收入份额。医院正在使用这些技术来满足日益增长的需求，以经济高效的方式简化其临床操作。医院是人们可以通过熟练的医务人员、行政人员、医疗设备等获得医疗服务的设施。

区域展望

溶酵素体贮积病治疗市场按北美、欧洲、亚太地区和拉美地区进行了分析。 2021年，北美分部在溶酵素体贮积病治疗市场中占据了最大的收入份额。归因于北美溶酵素体贮积病的高患病率。新医学疗法的发展、诊断技术的进步以及公众对溶酵素体贮积病的认识不断提高，正在推动这一市场的扩张。各国已使用不同的策略来满足其处理这一特殊高成本问题的需要。

内容

第一章市场范围和研究方法

  • 市场定义
  • 目的
  • 市场规模
  • 细分
    • 全球溶酵素体贮积病治疗市场，按疾病类型
    • 全球溶酵素体贮积病治疗市场，按治疗类型
    • 全球溶酵素体贮积病治疗市场，按最终用户分类
    • 按地区分列的全球溶酵素体贮积病治疗市场
  • 调查方法

第 2 章市场概述

  • 简介
    • 概览
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动力
    • 市场製约因素

第 3 章。全球溶酵素体贮积病治疗市场：按疾病类型分类

  • 全球戈谢病市场：按地区
  • 全球法布里病市场：按地区
  • 全球粘多醣贮积症市场：按地区划分
  • 庞贝综合症全球市场：按地区
  • 按地区划分的其他全球市场

第 4 章全球溶酵素体贮积病治疗市场：按治疗类型

  • 全球酵素替代疗法市场：按地区划分
  • 全球底物减少疗法市场：按地区划分
  • 全球干细胞治疗市场：按地区
  • 按全球地区划分的其他市场

第 5 章溶酵素体贮积病治疗的全球市场：按最终用户分类

  • 全球医院市场：按地区
  • 全球诊所市场：按地区
  • 按地区划分的世界其他市场

第 6 章。全球溶酵素体储存药物市场：按地区划分

  • 北美
    • 北美溶酵素体储存药物市场：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
      • 北美其他地区
  • 欧洲
    • 欧洲溶酵素体贮积病药物市场：按国家/地区分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲
  • 亚太地区
    • 亚太溶酵素体贮积症药物市场：按国家/地区分类
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • LAMEA
    • LAMEA 溶酵素体贮积症药物市场：按国家/地区分类
      • 巴西
      • 阿根廷
      • 阿联酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 其他 LAMEA

第七章公司简介

  • Merck & Co., Inc.
  • Johnson & Johnson（Janssen Global Services, LLC）
  • Eli Lilly And Company
  • Pfizer, Inc.
  • Takeda Pharmaceutical Company Limited
  • Sanofi S.A.
  • Novartis AG
  • AstraZeneca PLC（Alexion Pharmaceuticals, Inc.）
  • BioMarin Pharmaceutical Inc.
  • Sigilon Therapeutics, Inc.

The Global Lysosomal Disease Treatment Market size is expected to reach $11 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.

Lysosomal diseases (LSDs) are a complex group of metabolic disorders that are often inherited in an autosomal recessive manner. There are currently 45 known diseases. They are caused by malfunctions in various lysosomal processes, most often by abnormalities in genes that produce catabolic enzymes responsible for the breakdown of macromolecules. As the faulty enzyme accumulates substrate, cell malfunction and clinical symptoms escalate.

Other types of lysosomal dysfunction that can lead to lysosomal storage include defects in post-translational processing of lysosomal enzymes, errors in enzyme trafficking or targeting, and dysfunction of non-enzymatic transmembrane and solubilize.

Lysosomal hydrolase mutations, which are implicated in the breakdown of cellular macromolecules, are the primary cause of LSDs, accounting for more than two-thirds of cases. As a result, there are many different types of lipids, glycogen, mucopolysaccharides, and glycoproteins among the storage products in LSDs that are biochemical in origin. The LSDs are all inherited as autosomal recessive characteristics, except the X-linked Fabry, Danon, and Hunter diseases.

The LSDs can affect the majority of organs, either alone or as part of a multisystem illness, and are clinically very heterogeneous. Even though lysosomal enzymes are housekeeping genes and expressed in the majority of cells, the tissues on which they act are distributed much less uniformly, and this determines which tissues in any individual are affected.

COVID-19 Impact Analysis

The COVID-19 public health crisis has affected almost every industry. The COVID-19 outbreak has caused a significant decrease in demand for the lysosomal disease treatment size of the market across several sectors, especially the health and pharmaceutical sector, as coronavirus crises sweep the globe and force healthcare providers to devote a large percentage of their funds to fighting COVID-19. The risk of infection was the primary factor contributing to the delays in treatment that patients with lysosomal storage disorder encountered in hospitals. The COVID-19 outbreak harms the market's value in 2022 and beyond because it will delay the development of the worldwide market for lysosomal disease treatments.

Market Growth Factor

Incidence of Lysosomal Disorders Are Rising

The primary driving forces in the enzyme replacement therapy market are the expanding research and development for lysosomal disease diagnosis and drug development for treatment. The increasing incidence of lysosomal disease will be a key factor contributing to the acceleration of the market's growth rate. According to a report published by the National Center for Biotechnology Information, the prevalence of Fabry disease in communities of white, male individuals ranged from 1:17,000 to 1:117,000 in January 2020. Atypical presentations were associated with around 1:6000-1:40,000 females and 1:1000-1:3000 males, whereas 1:22,000-1:40,000 males had the classic Fabry disease mutations.

Financial Incentives for Developing Orphan Drugs to Recoup R&D Expenses

The increases in healthcare spending, which helps to improve its infrastructure, is a crucial element affecting the market's growth rate for therapies for lysosomal diseases. The market dynamics will be further impacted by various government organizations' efforts to strengthen the healthcare infrastructure by boosting funding. Additionally, the market for lysosomal disease therapies will grow as a result of the rising acceptance rate of early diagnosis and the increasing number of government programs to raise awareness. Along with this, expanding government benevolent programs and an increase in disposable money would accelerate market expansion.

Market Restraining Factor

The Treatment of Stem Cells Is Fraught with Issues

Many of the issues that can arise soon after the transplant are caused by the bone marrow being destroyed just before it by drugs or radiation. Some may be unintended consequences of the conditioning procedures themselves. The patient can get support from the transplant team to manage side effects. Most can be addressed to make the patient feel better, and some can be prevented. This is not a comprehensive list, so please inform the physician or the transplant team of any issues or adjustments that experience.

Disease Type Outlook

Based on the Disease Type, the Lysosomal Disease Treatment Market is segmented into Gaucher's Diseases, Fabry Diseases, Pompe's Syndrome, Mucopolysaccharidosis, and Others. The Gaucher's disease segment acquired the highest revenue share in the lysosomal disease treatment market in 2021. It is due to the rising prevalence of Gaucher's disease is the main market growth driver. Additionally, this segment's growth is fueled by potent approved medications and new treatments that are under development.

Type of Therapy Outlook

On the basis of Type of Therapy, the Lysosomal Disease Treatment Market is divided into Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, and Others. The stem cell therapy segment registered a substantial revenue share in the lysosomal disease treatment market in 2021. LSDs are a very appealing target for stem cell therapy due to the capacity to perform cross-correction through secretion-reuptake of lysosomal hydrolases, and allogeneic transplantation of bone marrow was the first specific therapeutic method to be applied to LSDs.

End User Outlook

By End-user, the Lysosomal Disease Treatment Market is bifurcated into Hospitals, Clinics, and Others. The hospital segment garnered the highest revenue share in the lysosomal disease treatment market in 2021. due to an increase in people seeking hospital care for lysosomal illnesses. In response to the rising demand for clinical practices to be streamlined cost-effectively, hospitals are using these technologies. A hospital is a facility with skilled medical staff, administrative staff, and medical equipment where people can receive medical care.

Regional Outlook

Region-wise, the Lysosomal Disease Treatment Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment acquired the largest revenue share in the lysosomal disease treatment market in 2021. Due to the lysosomal disease's high prevalence in North America. The development of new medical therapies, advancements in diagnostic technology, and growing public awareness of lysosomal disorders is fueling this market's expansion. Countries have used a variety of strategies that matched their particular needs to address this particular issue of high costs.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Eli Lilly And Company, Pfizer, Inc., Takeda Pharmaceutical Company Limited, Sanofi S.A., Novartis AG, AstraZeneca PLC (Alexion Pharmaceuticals, Inc.), BioMarin Pharmaceutical Inc. and Sigilon Therapeutics, Inc.

Scope of the Study

Market Segments covered in the Report:

By Disease Type

  • Gaucher's Diseases
  • Fabry Diseases
  • Mucopolysaccharidosis
  • Pompe's Syndrome
  • Others

By Type of Therapy

  • Enzyme Replacement Therapy
  • Substrate Reduction Therapy
  • Stem Cell Therapy
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Merck & Co., Inc.
  • Johnson & Johnson (Janssen Global Services, LLC)
  • Eli Lilly And Company
  • Pfizer, Inc.
  • Takeda Pharmaceutical Company Limited
  • Sanofi S.A.
  • Novartis AG
  • AstraZeneca PLC (Alexion Pharmaceuticals, Inc.)
  • BioMarin Pharmaceutical Inc.
  • Sigilon Therapeutics, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Lysosomal Disease Treatment Market, by Disease Type
    • 1.4.2 Global Lysosomal Disease Treatment Market, by Type of Therapy
    • 1.4.3 Global Lysosomal Disease Treatment Market, by End User
    • 1.4.4 Global Lysosomal Disease Treatment Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Lysosomal Disease Treatment Market by Disease Type

  • 3.1 Global Gaucher's Diseases Market by Region
  • 3.2 Global Fabry Diseases Market by Region
  • 3.3 Global Mucopolysaccharidosis Market by Region
  • 3.4 Global Pompe's Syndrome Market by Region
  • 3.5 Global Others Market by Region

Chapter 4. Global Lysosomal Disease Treatment Market by Type of Therapy

  • 4.1 Global Enzyme Replacement Therapy Market by Region
  • 4.2 Global Substrate Reduction Therapy Market by Region
  • 4.3 Global Stem Cell Therapy Market by Region
  • 4.4 Global Others Market by Region

Chapter 5. Global Lysosomal Disease Treatment Market by End User

  • 5.1 Global Hospitals Market by Region
  • 5.2 Global Clinics Market by Region
  • 5.3 Global Others Market by Region

Chapter 6. Global Lysosomal Disease Treatment Market by Region

  • 6.1 North America Lysosomal Disease Treatment Market
    • 6.1.1 North America Lysosomal Disease Treatment Market by Disease Type
      • 6.1.1.1 North America Gaucher's Diseases Market by Country
      • 6.1.1.2 North America Fabry Diseases Market by Country
      • 6.1.1.3 North America Mucopolysaccharidosis Market by Country
      • 6.1.1.4 North America Pompe's Syndrome Market by Country
      • 6.1.1.5 North America Others Market by Country
    • 6.1.2 North America Lysosomal Disease Treatment Market by Type of Therapy
      • 6.1.2.1 North America Enzyme Replacement Therapy Market by Country
      • 6.1.2.2 North America Substrate Reduction Therapy Market by Country
      • 6.1.2.3 North America Stem Cell Therapy Market by Country
      • 6.1.2.4 North America Others Market by Country
    • 6.1.3 North America Lysosomal Disease Treatment Market by End User
      • 6.1.3.1 North America Hospitals Market by Country
      • 6.1.3.2 North America Clinics Market by Country
      • 6.1.3.3 North America Others Market by Country
    • 6.1.4 North America Lysosomal Disease Treatment Market by Country
      • 6.1.4.1 US Lysosomal Disease Treatment Market
        • 6.1.4.1.1 US Lysosomal Disease Treatment Market by Disease Type
        • 6.1.4.1.2 US Lysosomal Disease Treatment Market by Type of Therapy
        • 6.1.4.1.3 US Lysosomal Disease Treatment Market by End User
      • 6.1.4.2 Canada Lysosomal Disease Treatment Market
        • 6.1.4.2.1 Canada Lysosomal Disease Treatment Market by Disease Type
        • 6.1.4.2.2 Canada Lysosomal Disease Treatment Market by Type of Therapy
        • 6.1.4.2.3 Canada Lysosomal Disease Treatment Market by End User
      • 6.1.4.3 Mexico Lysosomal Disease Treatment Market
        • 6.1.4.3.1 Mexico Lysosomal Disease Treatment Market by Disease Type
        • 6.1.4.3.2 Mexico Lysosomal Disease Treatment Market by Type of Therapy
        • 6.1.4.3.3 Mexico Lysosomal Disease Treatment Market by End User
      • 6.1.4.4 Rest of North America Lysosomal Disease Treatment Market
        • 6.1.4.4.1 Rest of North America Lysosomal Disease Treatment Market by Disease Type
        • 6.1.4.4.2 Rest of North America Lysosomal Disease Treatment Market by Type of Therapy
        • 6.1.4.4.3 Rest of North America Lysosomal Disease Treatment Market by End User
  • 6.2 Europe Lysosomal Disease Treatment Market
    • 6.2.1 Europe Lysosomal Disease Treatment Market by Disease Type
      • 6.2.1.1 Europe Gaucher's Diseases Market by Country
      • 6.2.1.2 Europe Fabry Diseases Market by Country
      • 6.2.1.3 Europe Mucopolysaccharidosis Market by Country
      • 6.2.1.4 Europe Pompe's Syndrome Market by Country
      • 6.2.1.5 Europe Others Market by Country
    • 6.2.2 Europe Lysosomal Disease Treatment Market by Type of Therapy
      • 6.2.2.1 Europe Enzyme Replacement Therapy Market by Country
      • 6.2.2.2 Europe Substrate Reduction Therapy Market by Country
      • 6.2.2.3 Europe Stem Cell Therapy Market by Country
      • 6.2.2.4 Europe Others Market by Country
    • 6.2.3 Europe Lysosomal Disease Treatment Market by End User
      • 6.2.3.1 Europe Hospitals Market by Country
      • 6.2.3.2 Europe Clinics Market by Country
      • 6.2.3.3 Europe Others Market by Country
    • 6.2.4 Europe Lysosomal Disease Treatment Market by Country
      • 6.2.4.1 Germany Lysosomal Disease Treatment Market
        • 6.2.4.1.1 Germany Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.1.2 Germany Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.1.3 Germany Lysosomal Disease Treatment Market by End User
      • 6.2.4.2 UK Lysosomal Disease Treatment Market
        • 6.2.4.2.1 UK Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.2.2 UK Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.2.3 UK Lysosomal Disease Treatment Market by End User
      • 6.2.4.3 France Lysosomal Disease Treatment Market
        • 6.2.4.3.1 France Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.3.2 France Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.3.3 France Lysosomal Disease Treatment Market by End User
      • 6.2.4.4 Russia Lysosomal Disease Treatment Market
        • 6.2.4.4.1 Russia Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.4.2 Russia Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.4.3 Russia Lysosomal Disease Treatment Market by End User
      • 6.2.4.5 Spain Lysosomal Disease Treatment Market
        • 6.2.4.5.1 Spain Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.5.2 Spain Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.5.3 Spain Lysosomal Disease Treatment Market by End User
      • 6.2.4.6 Italy Lysosomal Disease Treatment Market
        • 6.2.4.6.1 Italy Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.6.2 Italy Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.6.3 Italy Lysosomal Disease Treatment Market by End User
      • 6.2.4.7 Rest of Europe Lysosomal Disease Treatment Market
        • 6.2.4.7.1 Rest of Europe Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.7.2 Rest of Europe Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.7.3 Rest of Europe Lysosomal Disease Treatment Market by End User
  • 6.3 Asia Pacific Lysosomal Disease Treatment Market
    • 6.3.1 Asia Pacific Lysosomal Disease Treatment Market by Disease Type
      • 6.3.1.1 Asia Pacific Gaucher's Diseases Market by Country
      • 6.3.1.2 Asia Pacific Fabry Diseases Market by Country
      • 6.3.1.3 Asia Pacific Mucopolysaccharidosis Market by Country
      • 6.3.1.4 Asia Pacific Pompe's Syndrome Market by Country
      • 6.3.1.5 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy
      • 6.3.2.1 Asia Pacific Enzyme Replacement Therapy Market by Country
      • 6.3.2.2 Asia Pacific Substrate Reduction Therapy Market by Country
      • 6.3.2.3 Asia Pacific Stem Cell Therapy Market by Country
      • 6.3.2.4 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Lysosomal Disease Treatment Market by End User
      • 6.3.3.1 Asia Pacific Hospitals Market by Country
      • 6.3.3.2 Asia Pacific Clinics Market by Country
      • 6.3.3.3 Asia Pacific Others Market by Country
    • 6.3.4 Asia Pacific Lysosomal Disease Treatment Market by Country
      • 6.3.4.1 China Lysosomal Disease Treatment Market
        • 6.3.4.1.1 China Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.1.2 China Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.1.3 China Lysosomal Disease Treatment Market by End User
      • 6.3.4.2 Japan Lysosomal Disease Treatment Market
        • 6.3.4.2.1 Japan Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.2.2 Japan Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.2.3 Japan Lysosomal Disease Treatment Market by End User
      • 6.3.4.3 India Lysosomal Disease Treatment Market
        • 6.3.4.3.1 India Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.3.2 India Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.3.3 India Lysosomal Disease Treatment Market by End User
      • 6.3.4.4 South Korea Lysosomal Disease Treatment Market
        • 6.3.4.4.1 South Korea Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.4.2 South Korea Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.4.3 South Korea Lysosomal Disease Treatment Market by End User
      • 6.3.4.5 Singapore Lysosomal Disease Treatment Market
        • 6.3.4.5.1 Singapore Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.5.2 Singapore Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.5.3 Singapore Lysosomal Disease Treatment Market by End User
      • 6.3.4.6 Malaysia Lysosomal Disease Treatment Market
        • 6.3.4.6.1 Malaysia Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.6.2 Malaysia Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.6.3 Malaysia Lysosomal Disease Treatment Market by End User
      • 6.3.4.7 Rest of Asia Pacific Lysosomal Disease Treatment Market
        • 6.3.4.7.1 Rest of Asia Pacific Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.7.2 Rest of Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.7.3 Rest of Asia Pacific Lysosomal Disease Treatment Market by End User
  • 6.4 LAMEA Lysosomal Disease Treatment Market
    • 6.4.1 LAMEA Lysosomal Disease Treatment Market by Disease Type
      • 6.4.1.1 LAMEA Gaucher's Diseases Market by Country
      • 6.4.1.2 LAMEA Fabry Diseases Market by Country
      • 6.4.1.3 LAMEA Mucopolysaccharidosis Market by Country
      • 6.4.1.4 LAMEA Pompe's Syndrome Market by Country
      • 6.4.1.5 LAMEA Others Market by Country
    • 6.4.2 LAMEA Lysosomal Disease Treatment Market by Type of Therapy
      • 6.4.2.1 LAMEA Enzyme Replacement Therapy Market by Country
      • 6.4.2.2 LAMEA Substrate Reduction Therapy Market by Country
      • 6.4.2.3 LAMEA Stem Cell Therapy Market by Country
      • 6.4.2.4 LAMEA Others Market by Country
    • 6.4.3 LAMEA Lysosomal Disease Treatment Market by End User
      • 6.4.3.1 LAMEA Hospitals Market by Country
      • 6.4.3.2 LAMEA Clinics Market by Country
      • 6.4.3.3 LAMEA Others Market by Country
    • 6.4.4 LAMEA Lysosomal Disease Treatment Market by Country
      • 6.4.4.1 Brazil Lysosomal Disease Treatment Market
        • 6.4.4.1.1 Brazil Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.1.2 Brazil Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.1.3 Brazil Lysosomal Disease Treatment Market by End User
      • 6.4.4.2 Argentina Lysosomal Disease Treatment Market
        • 6.4.4.2.1 Argentina Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.2.2 Argentina Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.2.3 Argentina Lysosomal Disease Treatment Market by End User
      • 6.4.4.3 UAE Lysosomal Disease Treatment Market
        • 6.4.4.3.1 UAE Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.3.2 UAE Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.3.3 UAE Lysosomal Disease Treatment Market by End User
      • 6.4.4.4 Saudi Arabia Lysosomal Disease Treatment Market
        • 6.4.4.4.1 Saudi Arabia Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.4.2 Saudi Arabia Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.4.3 Saudi Arabia Lysosomal Disease Treatment Market by End User
      • 6.4.4.5 South Africa Lysosomal Disease Treatment Market
        • 6.4.4.5.1 South Africa Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.5.2 South Africa Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.5.3 South Africa Lysosomal Disease Treatment Market by End User
      • 6.4.4.6 Nigeria Lysosomal Disease Treatment Market
        • 6.4.4.6.1 Nigeria Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.6.2 Nigeria Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.6.3 Nigeria Lysosomal Disease Treatment Market by End User
      • 6.4.4.7 Rest of LAMEA Lysosomal Disease Treatment Market
        • 6.4.4.7.1 Rest of LAMEA Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.7.2 Rest of LAMEA Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.7.3 Rest of LAMEA Lysosomal Disease Treatment Market by End User

Chapter 7. Company Profiles

  • 7.1 Merck & Co., Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expenses
  • 7.2 Johnson & Johnson (Janssen Global Services, LLC)
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental &Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Eli Lilly And Company
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Acquisition and Mergers:
  • 7.4 Pfizer, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional & Segmental Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Partnerships, Collaborations, and Agreements:
  • 7.5 Takeda Pharmaceutical Company Limited
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional Analysis
    • 7.5.4 Research & Development Expense
  • 7.6 Sanofi S.A.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Approvals and Trials:
  • 7.7 Novartis AG
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 AstraZeneca PLC (Alexion Pharmaceuticals, Inc.)
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expenses
  • 7.9 BioMarin Pharmaceutical Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Regional Analysis
    • 7.9.4 Research & Development Expenses
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Approvals and Trials:
  • 7.10. Sigilon Therapeutics, Inc.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 Global Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 2 Global Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 3 Global Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 4 Global Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 5 Global Gaucher's Diseases Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Gaucher's Diseases Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Fabry Diseases Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Fabry Diseases Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Mucopolysaccharidosis Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Mucopolysaccharidosis Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Pompe's Syndrome Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Pompe's Syndrome Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 16 Global Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 17 Global Enzyme Replacement Therapy Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Enzyme Replacement Therapy Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Substrate Reduction Therapy Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Substrate Reduction Therapy Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Stem Cell Therapy Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Stem Cell Therapy Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 26 Global Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 27 Global Hospitals Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Hospitals Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Clinics Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Clinics Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 33 Global Lysosomal Disease Treatment Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Lysosomal Disease Treatment Market by Region, 2022 - 2028, USD Million
  • TABLE 35 North America Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 36 North America Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 37 North America Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 38 North America Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 39 North America Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Fabry Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Fabry Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 50 North America Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 51 North America Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 60 North America Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 61 North America Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 62 North America Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 63 North America Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 65 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 66 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 67 North America Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 69 US Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 70 US Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 71 US Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 72 US Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 73 US Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 74 US Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 75 US Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 76 US Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 77 Canada Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 78 Canada Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 79 Canada Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 80 Canada Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 81 Canada Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 82 Canada Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 83 Canada Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 84 Canada Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 85 Mexico Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 86 Mexico Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 87 Mexico Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 88 Mexico Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 89 Mexico Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 90 Mexico Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 91 Mexico Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 92 Mexico Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 93 Rest of North America Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 94 Rest of North America Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 95 Rest of North America Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 96 Rest of North America Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 97 Rest of North America Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 98 Rest of North America Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 99 Rest of North America Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 100 Rest of North America Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 101 Europe Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 102 Europe Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 103 Europe Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 104 Europe Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 105 Europe Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Fabry Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Fabry Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 116 Europe Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 117 Europe Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 120 Europe Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 121 Europe Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 124 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 125 Europe Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 126 Europe Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 127 Europe Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 128 Europe Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 129 Europe Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Europe Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 132 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 133 Europe Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Europe Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Germany Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 136 Germany Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 137 Germany Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 138 Germany Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 139 Germany Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 140 Germany Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 141 Germany Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 142 Germany Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 143 UK Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 144 UK Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 145 UK Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 146 UK Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 147 UK Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 148 UK Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 149 UK Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 150 UK Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 151 France Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 152 France Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 153 France Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 154 France Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 155 France Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 156 France Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 157 France Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 158 France Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 159 Russia Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 160 Russia Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 161 Russia Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 162 Russia Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 163 Russia Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 164 Russia Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 165 Russia Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 166 Russia Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 167 Spain Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 168 Spain Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 169 Spain Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 170 Spain Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 171 Spain Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 172 Spain Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 173 Spain Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 174 Spain Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 175 Italy Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 176 Italy Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 177 Italy Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 178 Italy Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 179 Italy Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 180 Italy Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 181 Italy Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 182 Italy Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 183 Rest of Europe Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 184 Rest of Europe Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 185 Rest of Europe Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 186 Rest of Europe Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 187 Rest of Europe Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 188 Rest of Europe Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 189 Rest of Europe Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 190 Rest of Europe Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Fabry Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Fabry Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 209 Asia Pacific Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 210 Asia Pacific Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 211 Asia Pacific Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 212 Asia Pacific Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 213 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 214 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 215 Asia Pacific Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 216 Asia Pacific Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 217 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 218 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 219 Asia Pacific Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 220 Asia Pacific Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 221 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 222 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 223 Asia Pacific Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 224 Asia Pacific Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 225 China Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 226 China Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 227 China Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 228 China Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 229 China Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 230 China Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 231 China Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 232 China Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 233 Japan Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 234 Japan Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 235 Japan Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 236 Japan Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 237 Japan Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 238 Japan Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 239 Japan Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 240 Japan Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 241 India Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 242 India Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 243 India Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 244 India Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 245 India Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 246 India Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 247 India Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 248 India Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 249 South Korea Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 250 South Korea Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 251 South Korea Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 252 South Korea Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 253 South Korea Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 254 South Korea Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 255 South Korea Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 256 South Korea Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 257 Singapore Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 258 Singapore Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 259 Singapore Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 260 Singapore Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 261 Singapore Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 262 Singapore Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 263 Singapore Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 264 Singapore Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 265 Malaysia Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 266 Malaysia Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 267 Malaysia Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 268 Malaysia Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 269 Malaysia Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 270 Malaysia Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 271 Malaysia Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 272 Malaysia Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 273 Rest of Asia Pacific Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 274 Rest of Asia Pacific Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 275 Rest of Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 276 Rest of Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 277 Rest of Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 278 Rest of Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 279 Rest of Asia Pacific Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 280 Rest of Asia Pacific Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 285 LAMEA Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 286 LAMEA Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 287 LAMEA Fabry Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 288 LAMEA Fabry Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 293 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 294 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 295 LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 296 LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 297 LAMEA Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 298 LAMEA Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 299 LAMEA Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 300 LAMEA Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 301 LAMEA Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 302 LAMEA Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 303 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 304 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 305 LAMEA Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 306 LAMEA Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 307 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 308 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 309 LAMEA Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 310 LAMEA Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 311 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 312 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 313 LAMEA Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 314 LAMEA Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 315 Brazil Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 316 Brazil Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 317 Brazil Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 318 Brazil Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 319 Brazil Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 320 Brazil Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 321 Brazil Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 322 Brazil Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 323 Argentina Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 324 Argentina Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 325 Argentina Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 326 Argentina Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 327 Argentina Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 328 Argentina Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 329 Argentina Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 330 Argentina Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 331 UAE Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 332 UAE Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 333 UAE Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 334 UAE Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 335 UAE Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 336 UAE Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 337 UAE Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 338 UAE Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 339 Saudi Arabia Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 340 Saudi Arabia Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 341 Saudi Arabia Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 342 Saudi Arabia Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 343 Saudi Arabia Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 344 Saudi Arabia Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 345 Saudi Arabia Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 346 Saudi Arabia Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 347 South Africa Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 348 South Africa Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 349 South Africa Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 350 South Africa Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 351 South Africa Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 352 South Africa Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 353 South Africa Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 354 South Africa Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 355 Nigeria Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 356 Nigeria Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 357 Nigeria Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 358 Nigeria Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 359 Nigeria Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 360 Nigeria Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 361 Nigeria Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 362 Nigeria Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 363 Rest of LAMEA Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 364 Rest of LAMEA Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 365 Rest of LAMEA Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 366 Rest of LAMEA Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 367 Rest of LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 368 Rest of LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 369 Rest of LAMEA Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 370 Rest of LAMEA Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 371 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 372 Key information -Johnson & Johnson
  • TABLE 373 Key Information - Eli Lilly And Company
  • TABLE 374 Key Information - Pfizer, Inc.
  • TABLE 375 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 376 Key Information - Sanofi S.A.
  • TABLE 377 Key Information - Novartis AG
  • TABLE 378 KEY INFORMATION - ASTRAZENECA PLC
  • TABLE 379 Key Information - BioMarin Pharmaceutical Inc.
  • TABLE 380 Key Information - Sigilon Therapeutics, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Lysosomal Disease Treatment Market Share by Disease Type, 2021
  • FIG 3 Global Lysosomal Disease Treatment Market Share by Disease Type, 2028
  • FIG 4 Global Lysosomal Disease Treatment Market by Disease Type, 2018 - 2028, USD Million
  • FIG 5 Global Lysosomal Disease Treatment Market Share by Type of Therapy, 2021
  • FIG 6 Global Lysosomal Disease Treatment Market Share by Type of Therapy, 2028
  • FIG 7 Global Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2028, USD Million
  • FIG 8 Global Lysosomal Disease Treatment Market Share by End User, 2021
  • FIG 9 Global Lysosomal Disease Treatment Market Share by End User, 2028
  • FIG 10 Global Lysosomal Disease Treatment Market by End User, 2018 - 2028, USD Million
  • FIG 11 Global Lysosomal Disease Treatment Market Share by Region, 2021
  • FIG 12 Global Lysosomal Disease Treatment Market Share by Region, 2028
  • FIG 13 Global Lysosomal Disease Treatment Market by Region, 2018 - 2028, USD Million